Suchergebnisse - "Shumilov, Evgenii"

PubPharm (5)

1

Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML

enthalten in: Leukemia & lymphoma | 2019

von Shumilov, E. | Flach, J. | Joncourt, R. | +8

2

Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations

enthalten in: Hematological oncology | 2019

von Shumilov, E. | Flach, J. | Joncourt, R. | +9

3

Coincidence of 5q deletion and the JAK2V617F mutation : report of two patients with overlapping myelodysplastic and myeloproliferative features and review of the literature

enthalten in: Leukemia & lymphoma | 2018

von Bürki, S. | Shumilov, E. | Bonadies, N. | +8

4

In Situ Validation of the Endothelial Cell Receptor GRP78 in a Case of Rhinocerebral Mucormycosis

enthalten in: Antimicrobial agents and chemotherapy | 2018

von Shumilov, E. | Bacher, U. | Perske, C. | +8

5

Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib

enthalten in: Leukemia & lymphoma | 2016

von Shumilov, E. | Wulf, G. | Ströbel, P. | +10

1
[1]